- Home
- MRLN vs SLP Comparison
MRLN vs SLP Comparison
Compare MRLN & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRLN | SLP |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | EDP Services |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.1M | 367.9M |
| IPO Year | 2024 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MRLN | SLP |
|---|---|---|
| Price | $4.15 | $18.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $25.00 | $24.00 |
| AVG Volume (30 Days) | ★ 2.3M | 673.1K |
| Earning Date | 10-28-2021 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ N/A | $42.42 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $4.16 | $11.09 |
| 52 Week High | $17.00 | $21.01 |
Technical Indicators
Market Signals| Indicator | MRLN | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 31.74 | 63.41 |
| Support Level | N/A | $17.74 |
| Resistance Level | $6.30 | $18.62 |
| Average True Range (ATR) | 0.52 | 0.16 |
| MACD | -0.04 | -0.11 |
| Stochastic Oscillator | 0.00 | 17.59 |
Price Performance
Historical ComparisonAbout MRLN Merlin Inc. Common Stock
Merlin Inc is focused on developing autonomous flight software for legacy and next-generation airborne systems. Its aircraft-agnostic, AI-based software supports takeoff-to-landing autonomous operations for military and civil aviation programs. The company aims to build an AI-based operating software platform intended to support autonomous flight operations across a range of aircraft types.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.